The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very little change other than tightening regulations and increased participant education of their rights.
8 Data Types to Collect Remotely
Decentralized clinical trials (DCT) are collecting many kinds of data remotely, and this data is only expected to grow in volume. From wireless patches monitoring vitals to an ever-growing list of mobile-connected products, there are new data sources popping up almost everywhere.
What is eConsent?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.
Case Study: COVID-RED Uses Castor’s Decentralized eClinical Platform
Download this case study to learn how Castor responded to the disruptive impact of COVID-19 and helped the COVID-RED study implement decentralized clinical trial methods to recruit over 17,825 participants in just 15 weeks.
Castor Leads Next-Gen Clinical Trials that Support Digital Therapeutics
Castor’s new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations by decentralizing clinical trials.
Developing an Infrastructure for Patient-Centric Decentralized Trials
Castor and Lightship discuss the infrastructure needs for providing the best patient experience and ensuring data integrity in decentralized clinical trials.
Three Ways Remote eConsent Improves Trial Efficiency
eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for clinical trials.
Castor is a Major Contender in Everest Group PEAK Matrix® of Decentralized Clinical Trial Products Assessment 2021
Download the “Decentralized Clinical Trial Products PEAK Matrix®” assessment by Everest Group to learn why Castor is a ‘Major Contendor’ provider of decentralized clinical trial products.
eConsent Readiness in 12 Countries
eConsent is imperative for continuing research during the COVID-19 pandemic and beyond, but regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 12 countries on the use of eSignature and eConsent in clinical trials.